Raveen Rathnasinghe

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Tisch Hospital

Texas Biomedical Research Institute

Quantitative BioSciences

Gladstone Institutes

Raveen Rathnasinghe is an author at Icahn School of Medicine at Mount Sinai specializing in infectious diseases, sars-cov-2 infection, and molecular virology.

ORCID

Publications per year

2014–2024

Publications

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Laura Riva, Shuofeng Yuan, Xin Yin et al. · Nature · 2020 · 856 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

Lisa Miorin, Thomas Kehrer, María Teresa Sánchez-Aparicio et al. · Proceedings of the National Academy of Sciences · 2020 · 568 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Kris M. White, Romel Rosales, Soner Yildiz et al. · Science · 2021 · 364 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer et al. · Science · 2021 · 223 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection

Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat et al. · Emerging Microbes & Infections · 2020 · 205 citations · Full text

Life Sciences, Infectious Diseases, Gene Delivery +16

1–5 of 40